[go: up one dir, main page]

DE60115647D1 - Verbindungen zur behandlung von beeinträchtigten fundischen entspannung - Google Patents

Verbindungen zur behandlung von beeinträchtigten fundischen entspannung

Info

Publication number
DE60115647D1
DE60115647D1 DE60115647T DE60115647T DE60115647D1 DE 60115647 D1 DE60115647 D1 DE 60115647D1 DE 60115647 T DE60115647 T DE 60115647T DE 60115647 T DE60115647 T DE 60115647T DE 60115647 D1 DE60115647 D1 DE 60115647D1
Authority
DE
Germany
Prior art keywords
compounds
treating impaired
fundamental relaxation
relaxation
fundamental
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60115647T
Other languages
English (en)
Other versions
DE60115647T2 (de
Inventor
Emelen Kristof Van
Bruyn Marcel F L De
Manuel J Alcazar-Vaca
Jose I Andres-Gil
F J Fernandez-Gadea
M E Matesanz-Ballesteros
J M Bartolome-Nebreda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Application granted granted Critical
Publication of DE60115647D1 publication Critical patent/DE60115647D1/de
Publication of DE60115647T2 publication Critical patent/DE60115647T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D411/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE60115647T 2000-06-22 2001-06-13 Verbindungen zur behandlung von beeinträchtigten fundischen entspannung Expired - Lifetime DE60115647T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00202180 2000-06-22
EP00202180 2000-06-22
PCT/EP2001/006749 WO2001098306A1 (en) 2000-06-22 2001-06-13 Compounds for treating impaired fundic relaxation

Publications (2)

Publication Number Publication Date
DE60115647D1 true DE60115647D1 (de) 2006-01-12
DE60115647T2 DE60115647T2 (de) 2006-08-24

Family

ID=8171674

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60115647T Expired - Lifetime DE60115647T2 (de) 2000-06-22 2001-06-13 Verbindungen zur behandlung von beeinträchtigten fundischen entspannung

Country Status (33)

Country Link
US (2) US7081453B2 (de)
EP (1) EP1296987B1 (de)
JP (1) JP4911860B2 (de)
KR (1) KR100821107B1 (de)
CN (2) CN100516066C (de)
AR (1) AR032158A1 (de)
AT (1) ATE312104T1 (de)
AU (1) AU783292B2 (de)
BG (1) BG65895B1 (de)
BR (1) BR0111859B1 (de)
CA (1) CA2410233C (de)
CZ (1) CZ305005B6 (de)
DE (1) DE60115647T2 (de)
EA (1) EA005760B1 (de)
EE (1) EE04878B1 (de)
EG (1) EG24462A (de)
ES (1) ES2254467T3 (de)
HR (1) HRP20020988B1 (de)
HU (1) HU227398B1 (de)
IL (2) IL153559A0 (de)
IS (1) IS2618B (de)
JO (1) JO2352B1 (de)
MX (1) MXPA02012844A (de)
MY (1) MY155267A (de)
NO (1) NO328547B1 (de)
NZ (1) NZ522519A (de)
PA (1) PA8519601A1 (de)
PL (1) PL201656B1 (de)
SA (1) SA01220442B1 (de)
SK (1) SK287730B6 (de)
UA (1) UA74576C2 (de)
WO (1) WO2001098306A1 (de)
ZA (1) ZA200210303B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20010868A2 (en) * 1999-06-02 2003-04-30 Janssen Pharmaceutica Nv Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
EA004648B1 (ru) 1999-06-02 2004-06-24 Янссен Фармацевтика Н.В. Пирролидинил-, пиперидинил- или гомопиперидинилзамещенные производные, способ их получения, их применение в медицине, содержащая их фармацевтическая композиция и способ ее получения
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus
JO2654B1 (en) * 2000-09-04 2012-06-17 شركة جانسين فارماسوتيكا ان. في Multiple aryl caroxa amides are useful as lipid - lowering agents
JO2409B1 (en) * 2000-11-21 2007-06-17 شركة جانسين فارماسوتيكا ان. في Second-phenyl carboxy amides are useful as lipid-lowering agents
HRP20160180T1 (hr) 2003-04-24 2016-03-25 Incyte Holdings Corp Derivati aza spiro alkana kao inhibitori metaloproteaza
JP4896476B2 (ja) * 2005-09-16 2012-03-14 広栄化学工業株式会社 メチルオキシメチルアミノピリジン誘導体及びその製造方法
US7999107B2 (en) 2007-01-31 2011-08-16 Merck Sharp & Dohme Corp. Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators
NZ580801A (en) * 2007-05-10 2012-09-28 Bristol Myers Squibb Co Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
CN103917529B (zh) 2011-11-11 2016-08-17 辉瑞大药厂 2-硫代嘧啶酮类
MA42035A (fr) 2015-05-05 2018-03-14 Pfizer 2-thiopyrimidinones
CN105481839B (zh) * 2015-11-23 2018-05-11 安徽千和新材料科技发展有限公司 一种光活性环氧啉对映体的制备方法
EP3229193A1 (de) 2016-04-07 2017-10-11 The Boeing Company Computerimplementiertes verfahren und system zur gemeinsamen nutzung von informationen zwischen passagieren und luftverkehrsmanagementakteuren

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910930A (en) * 1973-01-04 1975-10-07 Janssen Pharmaceutica Nv 1-{55 1-{8 2-(1,4-Benzodioxan-2-yl)-2-hydroxyethyl{9 -4-piperidyl{56 -2-benzimidazolinones
DE2400049A1 (de) * 1974-01-02 1975-07-10 Spumalit Anstalt Transportkasten aus kunststoff, insbesondere fuer flaschen
GR71865B (de) * 1978-03-20 1983-07-07 Ciba Geigy
US4329348A (en) * 1979-02-26 1982-05-11 Ciba-Geigy Corporation N-Oxacyclic-alkylpiperidines as psychostimulants
DE3484096D1 (de) * 1983-11-30 1991-03-14 Janssen Pharmaceutica Nv Bizyklisches heterozyklyl aufveisende n-(bizyklisches heterozyklyl-4-piperidinamine.
SI9300097B (en) 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines
CA2090767A1 (en) 1992-03-06 1993-09-07 Gerald Guillaumet 1,4-dioxino[2,3-b]pyridine derivatives
US6403103B1 (en) * 1994-08-12 2002-06-11 Bio Merieux Trypanosoma cruzi antigen, gene encoding therefore, and methods of detecting and treating chagas disease
FR2744451B1 (fr) * 1996-02-01 1998-04-24 Pf Medicament Nouvelles imidazolidinones, pyrimidinones, et 1,3-diazepin-2 -ones, leur preparation et leurs applications en therapeutique
US6133277A (en) * 1997-12-05 2000-10-17 Janssen Pharmaceutica N.V. (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
EA004648B1 (ru) * 1999-06-02 2004-06-24 Янссен Фармацевтика Н.В. Пирролидинил-, пиперидинил- или гомопиперидинилзамещенные производные, способ их получения, их применение в медицине, содержащая их фармацевтическая композиция и способ ее получения
HRP20010868A2 (en) 1999-06-02 2003-04-30 Janssen Pharmaceutica Nv Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
TWI225488B (en) * 1999-12-21 2004-12-21 Janssen Pharmaceutica Nv Derivatives of homopiperidinyl substituted benzimidazole analogues
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus

Also Published As

Publication number Publication date
JO2352B1 (en) 2006-12-12
DE60115647T2 (de) 2006-08-24
MXPA02012844A (es) 2003-05-15
HUP0301185A3 (en) 2009-03-30
HRP20020988A2 (en) 2005-02-28
CA2410233A1 (en) 2001-12-27
UA74576C2 (en) 2006-01-16
AU8386401A (en) 2002-01-02
PL201656B1 (pl) 2009-04-30
KR100821107B1 (ko) 2008-04-14
NO328547B1 (no) 2010-03-15
AU783292B2 (en) 2005-10-13
HU227398B1 (hu) 2011-05-30
JP4911860B2 (ja) 2012-04-04
EG24462A (en) 2009-07-16
BR0111859A (pt) 2003-05-13
SK287730B6 (en) 2011-07-06
US7081453B2 (en) 2006-07-25
IL153559A0 (en) 2003-07-06
IS6591A (is) 2002-10-25
BR0111859B1 (pt) 2015-01-06
BG107313A (bg) 2003-06-30
EP1296987B1 (de) 2005-12-07
PL358886A1 (en) 2004-08-23
EA005760B1 (ru) 2005-06-30
AR032158A1 (es) 2003-10-29
HK1057896A1 (en) 2004-04-23
CZ305005B6 (cs) 2015-03-25
CN1288157C (zh) 2006-12-06
CN100516066C (zh) 2009-07-22
SA01220442B1 (ar) 2008-05-21
CA2410233C (en) 2011-01-25
IL153559A (en) 2008-03-20
CN1781921A (zh) 2006-06-07
HRP20020988B1 (en) 2011-06-30
US20040019051A1 (en) 2004-01-29
CN1437602A (zh) 2003-08-20
ES2254467T3 (es) 2006-06-16
WO2001098306A1 (en) 2001-12-27
NZ522519A (en) 2003-09-26
ATE312104T1 (de) 2005-12-15
NO20026219D0 (no) 2002-12-23
EA200300049A1 (ru) 2003-04-24
JP2004501157A (ja) 2004-01-15
EE04878B1 (et) 2007-08-15
CZ2003115A3 (cs) 2003-06-18
IS2618B (is) 2010-04-15
BG65895B1 (bg) 2010-04-30
EE200200694A (et) 2004-06-15
MY155267A (en) 2015-09-30
HUP0301185A2 (hu) 2003-08-28
SK492003A3 (en) 2003-07-01
NO20026219L (no) 2003-02-17
US7423048B2 (en) 2008-09-09
ZA200210303B (en) 2004-03-19
KR20030007566A (ko) 2003-01-23
PA8519601A1 (es) 2002-08-26
EP1296987A1 (de) 2003-04-02
US20060142318A1 (en) 2006-06-29

Similar Documents

Publication Publication Date Title
DE60132089D1 (de) Vorrichtung zur behandlung von gasen miitels plasma
DE60124259D1 (de) Vorrichtung zur behandlung von migräne
ATE426373T1 (de) Apparat zur behandlung von zahnen
DE60020171D1 (de) Gerät zur behandlung von bandscheiben
DE60120520D1 (de) Verfahren zur behandlung von abwasser
EP1324780A4 (de) Methoden zur behandlung von herzarrhythmie
ATE323661T1 (de) Behandlung von mineralischen stoffen
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
DE60103770D1 (de) Botulinumtoxin zur behandlung endokriner erkrankungen
ATE259245T1 (de) Verfahren zur behandlung von beweggungsstörungen
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60142590D1 (de) Verwendung von Botulinum Toxin zur Behandlung von post-operative Schmerzen
DE60122532D1 (de) Verfahren zur behandlung von mehreren bohrlochintervallen
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE69935624D1 (de) Vorrichtung zur Behandlung von Banknoten
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE60112435D1 (de) Vorrichtung zur behandlung von abfällen
DE60143019D1 (de) Vorrichtung zur behandlung mit ozon
DE60122839D1 (de) Verfahren zur Behandlung von chromatbelastetem Abwasser
DE60014928D1 (de) Retinoide zur behandlung von emphysem
DE60114439D1 (de) Verfahren zur antimikrobiellen behandlung von fasermaterialien
DE60115647D1 (de) Verbindungen zur behandlung von beeinträchtigten fundischen entspannung
DE60035326D1 (de) Verfahren zur Behandlung von Abwasser
DE69835419D1 (de) Verfahren zur Behandlung von organischem Abwasser
DE60224650D1 (de) Vorrichtung zur behandlung von vorhof-fibrillation

Legal Events

Date Code Title Description
8364 No opposition during term of opposition